We participate in the K-HEALTHinAIR project - Knowledge to improve indoor air quality and health.

inBiot joins 15 partners from 8 European countries, led by the CARTIF Technology Center, to collaborate and achieve the objectives of the K-HEALTHinAIR project.

This consortium will provide a science-based assessment of the health effects of indoor air quality (IAQ) based on the results of clinical studies with 350 high-risk outpatients and comprehensive monitoring of chemical and biological indoor air pollutants. 

inBiot participates as a supplier of indoor air quality monitoring systems for mass monitoring campaigns in specific pilots in Spain, the Netherlands and Norway, also assisting in the development of action plans. In addition, inBiot is leading the development of a portable indoor air quality monitoring device solution ("User friendly solutions to monitor and improve IAQ. Action plans for scenarios").

This project represents a great opportunity to further deepen the knowledge and evaluation of the effects of indoor air quality on health.

‍VIDEO: inBiot's role in K-HEALTHinAIR

‍

K-HEALTHinAIR PROJECT

The effects of indoor air quality on human health are currently superficially analyzed in most environments (perhaps except in workplaces where legislation is more developed and strict). Additionally, vulnerable groups are not sufficiently protected under prevention criteria. K-HEALTHinAIR aims to implement a set of activities to create new relevant knowledge to meet this need. For this purpose, several highly representative indoor locations have been selected. To identify the determinants, an in-depth investigation of sources, interactions and main correlations with health problems will be carried out. As a result, the project will provide affordable measures to monitor and improve indoor air quality and guidelines to support actual interventions.

Recently funded by the European Union under the Horizon Europe Program, K-HEALTHinAIR proposes a multidisciplinary data collection (public health, IAQ and high-risk outpatient follow-up) including a three-year integrated monitoring campaign in 9 settings (hospital, subway station, market, nursing home, canteen, student residence, assembly hall, homes, schools) in 5 pilot studies in Europe. 

‍

‍

The European consortium includes 5 research and technology organizations (CARTIF acting also as coordinator, CSIC, CIEMAT, IDIBAPS & NOFER Institute), 2 hospitals (Clinic Hospital of Barcelona and Erasmus MC), 4 universities (Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Warsaw University of Technology, Medizinische Universität Wien and University of Agder), 2 industries (MANN+HUMMEL and Atos IT Solutions and Services), 2 SMEs (inBiot and KVELOCE) and a digital health connector (ECHAlliance).

‍

‍

Funded by the Horizon Europe program of the European Union under Grant Agreement number 101057693.

Funded by the Horizon Europe programme of the European Union under Grant Agreement number 101057693.